UBS Group AG - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 20 filers reported holding ALZAMEND NEURO INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q3 2023$1,879
+1323.5%
7,927
+2960.6%
0.00%
Q2 2023$132
-89.6%
259
-91.3%
0.00%
Q1 2023$1,264
-75.8%
2,973
-67.5%
0.00%
Q4 2022$5,221
-76.3%
9,159
-50.2%
0.00%
Q3 2022$22,000
+22.2%
18,403
-9.3%
0.00%
Q2 2022$18,000
-10.0%
20,282
+26.2%
0.00%
Q1 2022$20,000
+300.0%
16,076
+524.1%
0.00%
Q4 2021$5,000
-37.5%
2,576
-5.2%
0.00%
Q3 2021$8,000
-66.7%
2,717
+1.0%
0.00%
Q2 2021$24,0002,6910.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q3 2022
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$59,2500.00%
TRUIST FINANCIAL CORP 2,314,907$548,6330.00%
XTX Topco Ltd 12,974$3,0750.00%
UBS Group AG 7,927$1,8790.00%
IFP Advisors, Inc 5,000$1,1850.00%
OSAIC HOLDINGS, INC. 1,000$2370.00%
FMR LLC 268$640.00%
WELLS FARGO & COMPANY/MN 495$1170.00%
NORTHERN TRUST CORP 103,775$24,5950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALZAMEND NEURO INC shareholders